hemotune
The company develops a magnetic nanoparticle platform designed for highly selective separation in medical and industrial applications. Its technology uses HemoBeads and the HemoSystem to remove specific disease triggers directly from the bloodstream to treat conditions such as sepsis and to enable gene therapies. The platform is also applied to bioprocessing and advanced biomanufacturing to solve complex separation challenges.
Healthtech
Biotechnology
Nanotechnology
Medical Devices
Funding summary
- Total raised
- €4.7M
- Funding rounds
- 1
Investors in hemotune
Investors on record for hemotune. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like hemotune?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors